Otologic Pharmaceutics, Inc. (OPI) was founded in 2009 to develop novel therapeutics to prevent and restore hearing loss. OPI has a clinical-stage program for an oral medication for residual hearing loss protection in cochlear implants with secondary indications in Meniere’s Disease and tinnitus and preclinical programs focused on the restoration of hearing function resulting from chronic and age-related hearing loss. Currently, no pharmacological treatment for hearing loss is available. The status of OPI’s programs is as follows:
•NHPN-1010 (HPN-07 plus N-acetylcysteine, NAC) completed two Phase 1 safety/pharmacokinetic studies in healthy volunteers, and is anticipated to enter a Phase 2 trial in collaboration with Oblato.
•Preclinical siRNA program for regeneration of auditory sensory epithelia (hair cells) in the cochlea lost as a result of age-related hearing loss or chronic NIHL, has demonstrated restoration of auditory function in animal models of acute and chronic hearing loss.
Press Releases:
https://www.prnewswire.com/news-releases/oblato-biotech-company-acquires-hearing-loss-drug-discovered-by-hough-ear-institute-scientists-301003204.html
Company Details
- Founded
- -
- Address
- Oklahoma City, Oklahoma 73104, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://ascendbioventures.com/
- Keywords
- Oklahoma City.
- HQ
- Oklahoma City, Oklahoma
Otologic Pharmaceutics Questions
Otologic Pharmaceutics's website is https://ascendbioventures.com/
Otologic Pharmaceutics's LinkedIn profile is https://www.linkedin.com/company/otologic-pharmaceutics
Otologic Pharmaceutics's industry is
Pharmaceutical Manufacturing
Otologic Pharmaceutics's top competitors are
Spyryx Biosciences,
Frequency Therapies,
Akanocure Pharmaceuticals, Inc.,
Ascend Bioventures,
Cadenza Bio,
Aravis Biotech Llc,
Ina Pharmaceutics Inc,
Clairigene,
Stromatis Pharma Inc.,
Hough Ear Institute.
Otologic Pharmaceutics's categories are Pharmaceutical Manufacturing
Otologic Pharmaceutics's founding year is 2009
